Content
50%Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A thorough, well-sequenced clinical-genomics workflow with valuable ACMG/dosage reference material, but it is bloated and monolithic: redundant diagrams, pseudocode stubs with disclaimers, no explicit validation gates, and bundle-file references that do not exist.
Suggestions
Trim redundancy and pseudocode: remove the ASCII workflow box that duplicates the Phase Details headings, drop the score-visualization bars, and either make the Python examples executable or move them to a scripts/ file — keep SKILL.md focused on the decision logic and ACMG/dosage tables.
Apply progressive disclosure: split the worked 17q21.31 example, the full ACMG criteria tables, and the code implementations into references/ files (and create the referenced EXAMPLES.md/README.md or remove the dead 'See Also' links), leaving SKILL.md as a concise overview with one-level-deep links.
Add explicit validation checkpoints to the workflow — e.g., a gate after gene-content/dosage analysis confirming ClinGen scores were retrieved for every contained gene before scoring, and a reconcile step when population-frequency and ClinVar evidence conflict.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | The body is ~1350 lines with real padding — an ASCII workflow box that duplicates the phase headings, score-breakdown visualization bars, and Python stubs flagged 'This is pseudocode - actual implementation depends on available tools'. Not 3 because it is far from lean; not 1 because the bulk is domain-specific reference material (ACMG SV codes, dosage scoring) rather than generic concepts Claude already knows. | 2 / 3 |
Actionability | Concrete elements exist (named tool signatures like tu.tools.ClinGen_search_dosage_sensitivity(gene=...), ACMG criteria tables, report templates), but the code blocks are explicitly pseudocode with disclaimers and commented-out logic ('# inheritance_pattern = parse_inheritance(details)', 'May need to use myvariant'). Not 3 because the examples are not copy-paste executable; not 1 because the tables and tool calls are specific and instructive. | 2 / 3 |
Workflow Clarity | The 7 phases are clearly sequenced with goals and a 'Quantified Minimums' checklist, but validation/feedback checkpoints are implicit (evidence grading, completeness table) rather than explicit validate->fix->retry gates. Not 3 because explicit validation steps and error-recovery loops are absent; not 1 because the sequence and per-phase structure are unambiguous. | 2 / 3 |
Progressive Disclosure | Section organization is clear, but the document is a monolithic 1350-line wall with examples, full code, and report templates all kept inline, and 'See Also' references EXAMPLES.md/README.md that are not present in any bundle directory. Not 3 because nothing is actually split into bundle files; not 1 because references are one-level and sections are well organized. | 2 / 3 |
Total | 8 / 12 Passed |